Research led by the University of Cambridge Loke Center for Trophoblast Research has shown that a genome-editing technique can be used to alter a single gene in human embryonic cells, enabling the ...
Researchers at work in Sangamo Therapeutics' laboratory. The pioneer gene editing biotech company has filed for Chapter 11 bankruptcy protection, and has agreed to sell some of its programs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results